我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • Genamics 期刊搜索
  • 中国知网(CNKI)
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

New Scoring System Available at Home Health Care for Prediction of 14 Days Survival in Lung Cancer Complicated with Lymphangitic Carcinomatosis

Satomi Konno, Takuya Kishi, Hideyuki Kashiwagi, Takehiko Makino and Takeyuki Matsuguchi

Objective: Patients with lung cancer often greeted their terminal phase in the treatment at home, and many
cases complicated with lymphangitic carcinomatosis took a sudden turn. The aim of the present study was to
determine a scoring system available at home health care for prediction of short-term survival of lung cancer
complicated with lymphangitic carcinomatosis.
Methods: In 14 lung cancer patients with lymphangitic carcinomatosis in our medical care at home, we
determined significant close correlated and independent factors for assuming death during 14 days by logisticregression
analysis, and made out new scoring system. Moreover, we determined cut-off value on receiveroperating
characteristics analysis.
Results: In our scoring system calculated as the summation points awarded for the presence of 5 parameters
(i.e., systolic blood pressure<90 mmHg, 2 point; pulse rate>100 beats/minute, 3 point; blood oxygen
saturation<90%, 3 point; oxygen dose>2 L/minute, 2 point; respiratory frequency>20 times/minute, 3 point), cut-off
value was 8 (sensitivity 90%, specificity 68%).
Conclusions: We made a new a scoring system available at home health care for prediction of 14 days survival
of lung cancer complicated with lymphangitic carcinomatosis assumed systolic blood pressure, pulse rate,
respiratory frequency, blood oxygen saturation, and oxygen dose.